MAGLIO, ANGELANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 477
AS - Asia 441
EU - Europa 175
SA - Sud America 148
Continente sconosciuto - Info sul continente non disponibili 35
AF - Africa 10
OC - Oceania 1
Totale 1.287
Nazione #
US - Stati Uniti d'America 455
SG - Singapore 180
BR - Brasile 108
VN - Vietnam 93
IT - Italia 82
CN - Cina 72
IN - India 32
FI - Finlandia 19
DE - Germania 18
AR - Argentina 16
BD - Bangladesh 16
HK - Hong Kong 15
CA - Canada 10
EC - Ecuador 9
GB - Regno Unito 9
MX - Messico 8
ID - Indonesia 7
IE - Irlanda 6
IQ - Iraq 6
RU - Federazione Russa 6
FR - Francia 5
NL - Olanda 5
SE - Svezia 5
KE - Kenya 4
UA - Ucraina 4
VE - Venezuela 4
AT - Austria 3
CO - Colombia 3
ES - Italia 3
PE - Perù 3
PK - Pakistan 3
TR - Turchia 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
JO - Giordania 2
NP - Nepal 2
PL - Polonia 2
PY - Paraguay 2
AL - Albania 1
AU - Australia 1
BE - Belgio 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CY - Cipro 1
ET - Etiopia 1
GR - Grecia 1
IL - Israele 1
JP - Giappone 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MA - Marocco 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
SA - Arabia Saudita 1
SI - Slovenia 1
TN - Tunisia 1
Totale 1.252
Città #
San Jose 96
Singapore 91
Dallas 74
Ho Chi Minh City 46
Ashburn 45
Santa Clara 31
Council Bluffs 29
Bengaluru 25
Hefei 24
Beijing 17
Hanoi 14
Munich 14
Hong Kong 13
Turku 12
Chandler 10
Milan 9
São Paulo 9
Chicago 8
Helsinki 7
Naples 7
Boardman 6
Dublin 6
Haiphong 6
Lawrence 6
New York 6
Ninh Bình 6
Princeton 6
Los Angeles 5
Messina 5
Rome 5
Wilmington 5
Biên Hòa 4
Città Sant'Angelo 4
Houston 4
London 4
Nairobi 4
Palermo 4
Ankara 3
Baghdad 3
Belo Horizonte 3
Brooklyn 3
Guayaquil 3
Miami 3
Quito 3
Rimini 3
Rio de Janeiro 3
San Francisco 3
San Nicola Manfredi 3
São Luís 3
Thái Bình 3
Amman 2
Amsterdam 2
Belford Roxo 2
Boston 2
Buffalo 2
Colniza 2
Dhaka 2
Fisciano 2
Florence 2
Fortaleza 2
Hanover 2
Johannesburg 2
Lamezia Terme 2
Lima 2
Manaus 2
Manchester 2
Maracaibo 2
Medellín 2
Mexico City 2
Mirassol 2
Mumbai 2
Olomouc 2
Porto Alegre 2
Santa Maria 2
São Bernardo do Campo 2
Thái Nguyên 2
Toronto 2
Uberlândia 2
Warsaw 2
Addis Ababa 1
Aguascalientes 1
Ahmedabad 1
Al Kazimiyah 1
Ambato 1
Ananindeua 1
Anicuns 1
Aparecida de Goiânia 1
Arinos 1
As Sālimīyah 1
Astana 1
Asunción 1
Athens 1
Atlanta 1
Baltimore 1
Barquisimeto 1
Barreiras 1
Barueri 1
Bebedouro 1
Brasília 1
Brovary 1
Totale 785
Nome #
Arg16Gly 132-Adrenoreceptor Polymorphism in Severe Eosinophilic Asthma: Implications for Mepolizumab Long-Term Effectiveness and Clinical Remission 101
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study 72
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis 65
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 62
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets 59
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 58
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma 57
Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study 55
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 55
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13 51
Phenotyping severe asthma: a rationale for biologic therapy 51
Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting 48
Real-life effectiveness of mepolizumab on forced expiratory flow between 25% and 75% of forced vital capacity in patients with severe eosinophilic asthma 48
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 47
Tezepelumab: A potential new biological therapy for severe refractory asthma 47
Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy 46
Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients? 45
Novel Biological Therapies for Severe Asthma Endotypes 43
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 43
Chronic obstructive pulmonary disease and heart failure: Common diseases of the elderly, frequent non-recognition and the value of specialist referral 39
Pharmacotherapeutic strategies for critical asthma syndrome: a look at the state of the art 36
Novel Biological Therapies for Severe Asthma Endotypes 35
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 30
Effects of inhaled beclomethasone dipropionate/formoterol fumarate/glycopyrronium on diaphragmatic workload and lung function in uncontrolled asthma: a case report 30
Real-World Efficacy of Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium on Diaphragmatic Workload Assessed by Ultrasound and Lung Function in Patients with Uncontrolled Asthma 27
Biologic Therapy in Severe Asthma: A Phenotype-Driven and Targeted Approach 13
Key role of thymic stromal lymphopoietin as a molecular target for biologic treatment of severe asthma 13
Effect of the Arg16Gly β2‐Adrenergic Receptor Polymorphism on Long‐Term Mepolizumab Response and Clinical Remission in Severe Eosinophilic Asthma: A Genotype‐Stratified, Multicenter Study 11
Totale 1.287
Categoria #
all - tutte 9.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.452


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202223 0 0 2 4 2 1 1 5 3 3 2 0
2022/202344 14 3 8 0 2 1 1 2 3 1 8 1
2023/202447 13 4 6 2 2 6 1 2 1 4 4 2
2024/2025245 22 4 0 4 32 43 13 7 13 4 41 62
2025/2026881 46 87 130 181 91 52 77 49 87 48 16 17
2026/202744 11 33 0 0 0 0 0 0 0 0 0 0
Totale 1.287